The trial of a new antibiotic dirithromycin against acute pharyngitis and tonsillitis for safety and efficacy included 28 patients with acute tonsillitis and pharyngitis. Microbiological, biochemical, clinical and laboratory tests were conducted throughout the treatment and 2-3 weeks after the end of dirithromycin administration. The results support dirithromycin clinical potential in acute, chronic pharyngeal inflammation due to its high selective activity in relation to beta-hemolytic streptococcus A and the absence of side effects.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[dirithromycin antibiotic
4
antibiotic treatment
4
treatment pharyngeal
4
pharyngeal inflammation]
4
inflammation] trial
4
trial antibiotic
4
antibiotic dirithromycin
4
dirithromycin acute
4
acute pharyngitis
4
pharyngitis tonsillitis
4

Similar Publications

Article Synopsis
  • - A new, affordable potentiometric sensor for detecting erythromycin (ERY) uses circular carbon dots and incorporates nanomaterials (f-MWCNTs/PANi) to improve performance, offering high sensitivity and selectivity against other similar drugs.
  • - The sensor operates with a detection limit of 9.6 ± 0.4 × 10 M and shows excellent selectivity when tested against related substances like azithromycin and paracetamol, making it suitable for accurate drug monitoring.
  • - Validated for use in pharmaceutical formulations and human urine samples, the sensor demonstrates recovery rates between 93.0% and 104.3%, showcasing its effectiveness even in complex biological matrices with minimal sample volume needed.
View Article and Find Full Text PDF

Macrolide antibiotics, which are effective antimicrobial agents, are intensively used in human and veterinary medicine, as well as in agriculture. Consequently, they are found all over the world as environmental pollutants, causing harm to sensitive ecological communities and provoking a selection of resistant forms. A novel azithromycin derivative, which was used as hapten conjugate, ensured the group immunorecognition of six major macrolide representatives (105-41%), namely erythromycin, erythromycin ethylsuccinate, clarithromycin, roxithromycin, azithromycin, and dirithromycin in a competitive immunoassay based on anti-clarithromycin antibodies.

View Article and Find Full Text PDF

Due to the emergency and uncontrolled situation caused by the COVID-19 pandemic that arising in the entire world, it is necessary to choose available drugs that can inhibit or prevent the disease. Therefore, the repurposing of the commercial antibiotic, dirithromycin has been screened for the first time against fifteen receptors and compared to the azithromycin using a molecular docking approach to identify possible SARS-CoV-2 inhibitors. Our docking results showed that dirithromycin fit significantly in the Furin catalytic pocket having the lowest binding score (-9.

View Article and Find Full Text PDF

A lateral flow immunoassay (LFIA) using latex particles labeled with antibody to BSA-clarithromycin (CLA) was developed for the rapid simultaneous group determination of six macrolide antibiotics. Optimization of antigen spotting on the membrane and latex probe loading allowed improving visual detectability (vLOD) 100 times, which was 1, 1, 10, 10, 50, and 1000 ng/mL for CLA, roxithromycin, erythromycin, dirithromycin, azithromycin, and oleandomycin in buffer, respectively. The calculated limits of instrumental detection (cLOD) were respectively 0.

View Article and Find Full Text PDF

Macrolides are one of the most successful and widely used classes of antibacterials, which kill or stop the growth of pathogenic bacteria by binding near the active site of the ribosome and interfering with protein synthesis. Dirithromycin is a derivative of the prototype macrolide erythromycin with additional hydrophobic side chain. In our recent study, we have discovered that the side chain of dirithromycin forms lone pair-π stacking interaction with the aromatic imidazole ring of the His69 residue in ribosomal protein uL4 of the 70S ribosome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!